(Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Cash flow from operating activities | ||||||||||
Earning before tax | ---- | ---- | ---- | 42.31%4.24B | ---- | ---- | ---- | 173.64%2.98B | ---- | ---- |
Profit adjustment | ||||||||||
Interest (income) - adjustment | ---- | ---- | ---- | -46.75%-181.13M | ---- | ---- | ---- | 0.40%-123.43M | ---- | ---- |
Investment loss (gain) | ---- | ---- | ---- | 8.30%-14.95M | ---- | ---- | ---- | 63.40%-16.31M | ---- | ---- |
Attributable subsidiary (profit) loss | ---- | ---- | ---- | 37.99%-178.31M | ---- | ---- | ---- | 22.91%-287.56M | ---- | ---- |
Impairment and provisions: | ---- | ---- | ---- | -7.63%66.63M | ---- | ---- | ---- | -96.45%72.13M | ---- | ---- |
-Impairment of property, plant and equipment (reversal) | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -98.50%30.2M | ---- | ---- |
-Impairmen of inventory (reversal) | ---- | ---- | ---- | 234.00%10.05M | ---- | ---- | ---- | -242.10%-7.5M | ---- | ---- |
-Impairment of trade receivables (reversal) | ---- | ---- | ---- | 14.45%56.58M | ---- | ---- | ---- | 213.71%49.44M | ---- | ---- |
Revaluation surplus: | ---- | ---- | ---- | -9.00%-71.14M | ---- | ---- | ---- | -4.02%-65.26M | ---- | ---- |
-Other fair value changes | ---- | ---- | ---- | -9.00%-71.14M | ---- | ---- | ---- | -4.02%-65.26M | ---- | ---- |
Asset sale loss (gain): | ---- | ---- | ---- | 58.17%37.26M | ---- | ---- | ---- | -58.24%23.56M | ---- | ---- |
-Loss (gain) on sale of property, machinery and equipment | ---- | ---- | ---- | 58.17%37.26M | ---- | ---- | ---- | -58.24%23.56M | ---- | ---- |
Depreciation and amortization: | ---- | ---- | ---- | 11.04%5.61B | ---- | ---- | ---- | 3.82%5.05B | ---- | ---- |
-Depreciation | ---- | ---- | ---- | 10.88%5.2B | ---- | ---- | ---- | 4.04%4.69B | ---- | ---- |
Financial expense | ---- | ---- | ---- | 26.95%969.39M | ---- | ---- | ---- | -6.60%763.6M | ---- | ---- |
Exchange Loss (gain) | ---- | ---- | ---- | 106.56%37.14M | ---- | ---- | ---- | -442.13%-565.85M | ---- | ---- |
Special items | ---- | ---- | ---- | -3,636.24%-13.3M | ---- | ---- | ---- | -112.05%-356K | ---- | ---- |
Operating profit before the change of operating capital | ---- | ---- | ---- | 34.08%10.51B | ---- | ---- | ---- | -7.03%7.83B | ---- | ---- |
Change of operating capital | ||||||||||
Inventory (increase) decrease | ---- | ---- | ---- | 23.73%178.76M | ---- | ---- | ---- | 138.82%144.47M | ---- | ---- |
Accounts receivable (increase)decrease | ---- | ---- | ---- | 81.61%-407.69M | ---- | ---- | ---- | -339.80%-2.22B | ---- | ---- |
Accounts payable increase (decrease) | ---- | ---- | ---- | 69.79%2.44B | ---- | ---- | ---- | 823.88%1.44B | ---- | ---- |
prepayments (increase)decrease | ---- | ---- | ---- | 398.56%67.72M | ---- | ---- | ---- | 122.15%13.58M | ---- | ---- |
Special items for working capital changes | ---- | ---- | ---- | 54.00%811.79M | ---- | ---- | ---- | 44.04%527.13M | ---- | ---- |
Cash from business operations | ---- | ---- | ---- | 75.65%13.59B | ---- | ---- | ---- | -3.39%7.74B | ---- | ---- |
China income tax paid | ---- | ---- | ---- | 61.67%-246.71M | ---- | ---- | ---- | -85.00%-643.64M | ---- | ---- |
Other taxs | ---- | ---- | ---- | -29.98%-256.02M | ---- | ---- | ---- | 19.47%-196.97M | ---- | ---- |
Special items of business | ---- | 48.61%1.71B | ---- | ---- | ---- | 155.24%1.15B | ---- | ---- | ---- | -10.55%-2.09B |
Adjustment items of business operations | 20.12%5.12B | ---- | -767.78%-834.95M | ---- | 1,005.00%4.26B | ---- | 95.67%-96.22M | ---- | -797.59%-470.8M | ---- |
Net cash from operations | 20.12%5.12B | 48.61%1.71B | -767.78%-834.95M | 89.77%13.09B | 1,005.00%4.26B | 155.24%1.15B | 95.67%-96.22M | -7.00%6.9B | -797.59%-470.8M | -10.55%-2.09B |
Cash flow from investment activities | ||||||||||
Interest received - investment | ---- | 26.89%58.49M | ---- | 88.23%119.58M | ---- | 171.06%46.09M | ---- | -5.69%63.53M | ---- | -74.16%17.01M |
Dividend received - investment | 100.94%365.37M | -32.06%25.29M | 2,562.49%195.85M | -44.28%102.29M | 12.17%181.83M | -61.44%37.23M | -90.44%7.36M | -7.65%183.59M | -19.62%162.1M | 501.85%96.54M |
Sale of fixed assets | 39.23%15.91M | 51.08%15.58M | 100.10%2.1M | 210.75%101.69M | 80.64%11.43M | 1,486.46%10.31M | 528.61%1.05M | 43.45%32.72M | 10.63%6.32M | -85.34%650K |
Purchase of fixed assets | -53.45%-4.68B | -37.19%-2.34B | -48.47%-1.56B | -124.70%-9.29B | -86.05%-3.05B | -34.45%-1.7B | -77.54%-1.05B | -12.19%-4.14B | 10.90%-1.64B | 5.20%-1.27B |
Sale of subsidiaries | ---- | ---- | ---- | -56.13%2.86M | ---- | ---- | ---- | --6.52M | ---- | --6.52M |
Acquisition of subsidiaries | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --345.84M | ---- | ---- |
Recovery of cash from investments | 72.45%8.45B | 124.15%8.17B | 200.00%3B | -9.40%6.64B | -22.30%4.9B | -31.87%3.64B | -47.37%1B | -22.41%7.33B | -2.98%6.31B | -4.56%5.35B |
Cash on investment | ---- | -30,420.86%-2.54B | ---- | 32.08%-5.13B | ---- | -186.24%-8.32M | ---- | 29.89%-7.56B | ---- | 99.89%-2.91M |
Other items in the investment business | -9,929,497.53%-2.44B | --327K | -6,644.96%-1.97B | 315.80%4.16M | 100.00%-24.57K | ---- | 132.05%30.07M | -82.17%1M | 83.04%-716.1M | ---- |
Net cash from investment operations | -16.18%1.71B | 67.34%3.39B | -2,118.70%-333.92M | -99.78%-7.46B | -50.36%2.05B | -51.76%2.03B | -101.08%-15.05M | 21.05%-3.73B | 537.15%4.12B | 132.00%4.2B |
Net cash before financing | 8.34%6.83B | 60.54%5.1B | -950.50%-1.17B | 77.96%5.63B | 72.78%6.31B | 50.60%3.18B | 86.55%-111.27M | 17.68%3.17B | 411.03%3.65B | 2,776.47%2.11B |
Cash flow from financing activities | ||||||||||
New borrowing | --0 | ---- | ---- | -36.67%3.49B | -65.88%1.83B | ---- | ---- | --5.52B | --5.36B | ---- |
Refund | -22.86%-2.72B | -13,863.76%-1.27B | -768.28%-678.44M | -20,097.77%-3.68B | 74.44%-2.21B | 0.00%-9.1M | -1.12%-78.14M | 0.00%-18.2M | -5,540.08%-8.65B | 0.00%-9.1M |
Interest paid - financing | ---- | 3.48%-475.86M | ---- | -13.63%-947.96M | ---- | -8.00%-493.04M | ---- | -3.54%-834.28M | ---- | -6.18%-456.53M |
Dividends paid - financing | -14.80%-1.75B | -34.24%-1.08B | -15.88%-244.14M | -10.13%-953.46M | -9.05%-1.52B | -12.26%-803.46M | -11.69%-210.69M | -6.73%-865.74M | 2.94%-1.4B | 11.76%-715.74M |
Issuance expenses and redemption of securities expenses | ---- | ---- | ---- | 91.22%-728.62M | ---- | ---- | ---- | -264.89%-8.29B | ---- | ---1.5B |
Net cash from financing operations | -134.60%-4.46B | -96.89%-3.02B | -219.43%-922.58M | 32.54%-3.28B | 59.36%-1.9B | 46.03%-1.53B | -8.62%-288.82M | -16.01%-4.87B | -194.23%-4.68B | -112.33%-2.84B |
Effect of rate | -129.87%-39.62M | -115.25%-22.14M | -575.55%-4.09M | -74.69%65.05M | -30.27%132.67M | -19.78%145.17M | 106.74%859.12K | 458.14%257.05M | 1,546.62%190.27M | 557.87%180.97M |
Net Cash | -46.21%2.37B | 26.62%2.08B | -422.75%-2.09B | 238.14%2.35B | 526.70%4.4B | 324.45%1.64B | 63.41%-400.09M | -13.03%-1.7B | -17.68%-1.03B | 48.34%-732.64M |
Begining period cash | 67.83%5.98B | 67.83%5.98B | 67.83%5.98B | -28.86%3.56B | -28.86%3.56B | -28.86%3.56B | -28.86%3.56B | -23.96%5.01B | -23.96%5.01B | -23.96%5.01B |
Cash at the end | 2.58%8.31B | 50.20%8.04B | 22.75%3.88B | 67.83%5.98B | 94.44%8.1B | 20.13%5.35B | -18.92%3.16B | -28.86%3.56B | -26.85%4.16B | -13.10%4.45B |
Cash balance analysis | ||||||||||
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | CAS (2007) | HKAS | CAS (2007) | HKAS | CAS (2007) | HKAS | CAS (2007) | HKAS | CAS (2007) | HKAS |
Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- | -- |
Auditor | -- | -- | -- | Ernst & Young Huaming (Special General Partnership), Ernst & Young | -- | -- | -- | Ernst & Young Huaming (Special General Partnership), Ernst & Young | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data